TRUNCATED ALPHAA AND ALPHAB CRYSTALLINS
TRUNCATED ALPHAA AND ALPHAB CRYSTALLINS
批准号:
8361687
负责人:
DAVID EISENBERG
金额:
$1.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31
关键词:
BindingC-terminalCattleCrystalline LensCrystallinsCrystallizationFundingGrantHeat shock proteinsHumanMolecularMolecular ChaperonesNational Center for Research ResourcesPreventionPrincipal InvestigatorResearchResearch InfrastructureResourcesRunawaySourceStructureUnited States National Institutes of Healthalpha-Crystallinsamyloid formationbeta pleated sheetcostprotein aggregationstructural biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Small heat shock proteins alphaA and alphaB crystallin form highly polydisperse oligomers that frustrate protein aggregation, crystallization, and amyloid formation. Here, we present the crystal structures of truncated forms of bovine alphaA crystallin (AAC(59-163)) and human alphaB crystallin (ABC(68-162)), both
containing the C-terminal extension that functions in chaperone action and oligomeric assembly. In both structures, the C-terminal extensions swap into neighboring molecules, creating runaway domain swaps. This interface, termed DS, enables crystallin polydispersity because the C-terminal extension is palindromic and thereby allows the formation of equivalent residue interactions in both directions. That is, we observe that the extension binds in opposite directions at the DS interfaces of AAC(59-163) and ABC(68-162). A second dimeric interface, termed AP, also enables polydispersity by forming an antiparallel beta sheet with three distinct registration shifts. These two polymorphic interfaces enforce polydispersity of alpha crystallin. This evolved polydispersity suggests molecular mechanisms for chaperone action and for prevention of crystallization, both necessary for transparency of eye lenses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10370874
-
项目类别:
-
资助金额:$106.84万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10544785
-
项目类别:
-
资助金额:$119.25万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10209753
-
项目类别:
-
资助金额:$156.98万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10657390
-
项目类别:
-
资助金额:$155.45万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10436894
-
项目类别:
-
资助金额:$154.49万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10330046
-
项目类别:
-
资助金额:$107.56万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10155527
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10641815
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10460922
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
Structure and Inhibition of Amyloid in Alzheimer's Disease
-
批准号:9194224
-
项目类别:
-
资助金额:$377.99万
-
财政年份:2016
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9428606
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9334041
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8916013
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8752398
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE
-
批准号:8361684
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MYCOBACTERIUM TUBERCULOSIS RV3019C-RV3020C ESX COMPLEX
-
批准号:8361683
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
?2-MICROGLOBULIN
-
批准号:8361688
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MOLECULAR MECHANISMS FOR PROTEIN-ENCODED INHERITANCE
-
批准号:8169290
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
STRUCTURE/ACTIVITY OF A MEMBER OF THE VAPBC FAMILY OF TOXIN ANTITOXIN SYSTEMS
-
批准号:8169257
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
MOLECULAR BASIS FOR INSULIN FIBRIL ASSEMBLY
-
批准号:8169254
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
国内基金
海外基金
MUC16 C-terminal/AKT/HK2信号轴在Lewis抗原阴性胰腺癌侵袭转移中的作用及机制研究
-
批准号:82072693
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘辰
-
依托单位:
靶向转导Gαi2 C-terminal peptide基因去迷走神经治疗心房颤动的实验研究
-
批准号:81260037
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2012
-
负责人:汤宝鹏
-
依托单位: